September 10, 2014 — A lawsuit has been filed in California federal court by a woman who was diagnosed with peripheral neuropathy (nerve damage) after taking Levaquin (levofloxacin), a popular antibiotic.
The lawsuit was filed on August 6 in the U.S. District Court for the Northern District of California.
The plaintiff, Karyn Joy Grossman of Baltimore, Maryland, alleges that Levaquin caused her to develop peripheral neuropathy after she took the medication as directed.
According to the complaint (PDF):
“The warning label for Levaquin during the period from September 2004 through August 2013 misled Plaintiff and her treating physician by incorrectly advising patients and physicians that peripheral neuropathy associated with Levaquin was “rare” and in any case could be avoided by discontinuing the drug upon the onset of certain symptoms.”
The lawsuit alleges that peripheral neuropathy cannot always be avoided by discontinuing Levaquin. In addition, information about this debilitating side effect was “buried at the bottom of a long list of adverse reactions.”
Although warnings about peripheral neuropathy were added to the label in 2004, dozens of case reports linking fluoroquinolone antibiotics with nerve damage were published throughout the 1990s. In 2001, a study of 45 cases found that most cases occurred within a week, 80% were “severe,” and over 60% persisted for at least one year.
It was not until August 2013 that the FDA published a Safety Communication to emphasize that nerve damage from Levaquin could occur rapidly and cause permanent complications.
The Prescribing Information now warns that Levaquin should be discontinued if patients develop symptoms like pain, burning, tingling, numbness, muscle weakness, or changes in the senses (texture, temperature, position, vibration, etc.).
Do I have a Levaquin Lawsuit?
The Schmidt Firm, PLLC is currently accepting Levaquin induced injury cases in all 50 states. If you or somebody you know has been diagnosed with nerve damage (peripheral neuropathy), you should contact our lawyers immediately for a free case consultation. Please use the form below to contact our Defective Drug Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us a case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.